AndroGel Patent Suit Ruled Baseless For Antitrust Claims
A Pennsylvania federal court ruled that an infringement case filed in 2011 by AbbVie and Besins over AndroGel was objectively baseless, siding with drug wholesalers on a key allegation in their suit...To view the full article, register now.
Already a subscriber? Click here to view full article